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1799-41 The ImprOVed Prognosis of Idiopathic Dilated
Cardiomyopathy in the Era of Modern Therapeutics
Jonathan H. Goldman, Philip J. Keeling. Alistair Slade, Perry Elliott, Alida Caforio.
Jan Poloniecki, William J. McKenna. St George's Hospital, UK
Early reports indicated a poor prognosis for Dilated cardiomyopathy (DCM)
(annual mortality of >25%). Intervention with angiotensin converting enzyme
inhibitors (ACE), cardiac transplantation (Tx) and implantable cardioverter de-
fibrillators (lCD) can improve survival in patients with heart failure. To re-
assess the clinical outcome of DCM where these treatments have been ap-
plied, we studied 172 consecutive patients with DCM (WHO criteria) referred
to our hospital between 1989-1993. One hundred and sixteen patients were
referred for management of heart failure (Group I), 30 for specific arrhythmia
management, including 5 patients who had survived out of hospital cardiac
arrest (Group II). and 26 for Tx assessment (Group III). The age (+SD) of pa-
tients were 42 ± 14,42 ± 16 and 48 ± 7 y.
Group I In = 1161 II (n = 30) III (n ~ 26)
tected in initial (I NIT: 30 min) and delayed (DEL: 4 hr) images and the percent
washout (WR) of MIBG from myocardium was obtained from them. Left ven-
tricularfractional shortening (LVFSI was measured with echocardiography. In
19 pts, 12 had good response to B therapy, but 7 failed in this therapy be-
cause of advanced heart failure.
Results are shown below (Data are shown by Mn ± SD).
responded not responded
No of pts 12 7
NYHA class III 9 2
class IV 3 5
LVFS 14 ± 4 10 ± 4 (p < 0.05)
HIM INIT 2.45 ± 060 1.78 ± 0.48 (p < 005)
DEL 2.28 ± 059 141 ± 0.29 (p < 0.01)
WR 37± 11% 47 ± 12% (NS)
Conclusion: These results demonstrated that MIBG HIM ratio (> 1.7:
mean-SD in responded pts) in DEL images is a better marker to find out
pts responded to B therapy in DCM, than WR or NYHA class.
LVDO = left ventricular diastolic diameter, EF = ejection fraction
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1799-611-123 Metaiodobenzylguanidine Scintigraphy for the
Prediction of Response to Beta Blocker Treatment in
Patients with Dilated Cardiomyopathy
Joel Eusebio, Eva V. Chomka, Tyrone Daniels, Stuart Rich, Bruce H. Brundage,
Christopher J. Wolfkiel University of Illinois at Chicago and Harbour UCLA
Long term changes in coronary artery calcification (CAC) by ultrafast com-
puted tomography (UFCT) has not been investigated. One hundred twenty
five, 74 m 50 f, (50.5 ± 8.63 yrs) initially asymptomatic at risk subjects were
scanned 61.1 ± 4.0 months apart. CAC was scored by Agatston's method,
a score of 1 or greater was considered positive. At baseline, 45 subjects
had CAC (151.3 ± 225.3). 46.7% with scores of 40 or less. At follow-up, 60
subjects were positive (311.1 ± 411.7),38.3% with scores of 40 or less. A
Wilcoxon rank sum showed significant increases of the initial45 positive sub-
jects (p < 0.001). The majority of new CAC were less than 40 (14/16) (23.2 ±
47.8). One subject had a score of 5 at baseline and 0 at follow up. Seven sub-
jects, 6 with CAC, went on to develop clinical coronary artery disease (CAD).
Development of CAD was significantly associated with CAC increases of 40
or greater (6/35 vs 0/25, n = 45, p = 0.0359 Fisher's Exact Test). Increases in
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Total Coronary Calcified Volume is Highly Correlated
with Total Plaque Volume: A Histologic Study of 723
Segments
Giuseppe Sangiorgi, Sanjay S. Srivatsa, Michael Staab, John A. Rumberger,
Rachel Kaufman, Patricia Peyser, Lorraine A. Fitzpatrick, Robert S. Schwartz Mayo
Clinic, Rochester, MN 55905
The quantitative relationship between calcification of the coronary artery wall
and the atherosclerotic plaque area has not been defined. This relationship
may have substa ntial importance because Electron Seam CT (EBCT) can non-
invasively measure volume of coronary calcification in the living patient. We
thus studied the three major coronary arteries of 13 autopsy derived hearts.
The arteries were sectioned at 3 mm intervals reSUlting in 723 sections. All
vessels were processed with non-decalcifying methodology in order to com-
pletely preserve the amount of calcium in the vessel. Areas enclosed by the
arterial lumina and internal and external elastic lamina (IEL and EEL) were
planimetered with a calibrated digital computer. Calcified area in each section
was measured densitometrically by pixel counting in digital image analysis.
Plaque area was calculated as the difference (IEL-Lumen) area, as was his-
tologic percent stenosis (% Sten). A highly significant relationship between
calcific volume and plaque area was found (r = 0.68). Conversely, a poor
relationship existed between the artery lumen size (r = 0.17) and percent
histologic stenosis (r = 0.4).
Conclusion: Histologic coronary arterial calcification correlates well with
total plaque area and poorly with percent histologic stenosis. Lumen area,
and by extension angiographic stenosis correlates poorly with calcium. The
total plaque area of all segments appears to be accurately estimated by cal-
cific area, suggesting that calcification by UFCT may be used to determine
total plaque volume in the coronary trees of living patients.
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1800 I The Value and Meaning of Coronary Calcium
Detection by Ultrafast CT
Wednesday, March 22,1995,2:00 p.m.-3:30 p.m,
Ernest N. Morial Convention Center, Room 24
1800-21 Five Year Changes in Coronary Calcification by
Ultrafast Computed Tomography
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During follow-up (26 ± 29 m) 154 patients (90%) received ACE, 50 (29%)
were anticoagulated, 29 (17%) received digoxin, 52 (30%) received amio-
darone, 5 (3%) received an ICD and 2 underwent radio-frequency ablation (n
= 2, 1%). Sixty patients suffered Progressive Heart Failure (PHF) of whom
5 patients died of PHF and 1 from PE, 46 required Tx (5 of these died dur-
ing FU) and 8 continue to deteriorate. Sudden death (SD) occurred in 8 (6%)
patients (5 group I, 2 group II, I group III). 18% (n = 18) of the remaining
102 patients experienced complications of heart failure (2 aborted sudden
cardiac death, 6 refractory atrial arrhythmias of whom two required catheter
ablation, 6 pacemaker insertions, 4 thromboembolic events). The 1 and 2
year mortality for DCM patients was 6% (2-10) and 7% (3-12) respectively
and the 1 and 2 year probability of death or transplantation was 16% (95%
CI; 9-22) and 21 % (13-29) respectively. In conclusion annual mortality in our
cohort of DCM patients has improved. This is unlikely to be due to Tx alone
and also reflects access to drugs and ICD. However prevention of SD remains
a problem.
Point mutations of mitochondrial DNA (mtDNA) were reported in various dis-
eases. We studied them in patients with alcoholic heart muscle disease
(AHMD). In habitual heavy drinkers with heart failure (ten men, mean age
53.1 ± 8.2 years, mean daily ethanol intake 119.5 ± 40.0 ml, mean drink-
ing duration 30.3 ± 7.9 years). right ventricular endomyocardial biopsies
were performed. MtDNA was extracted from the specimens and ampli-
fied using PCR. Then the total base-sequence was analysed and compared
with the wild type. Eight point mutations which cause amino acid substi-
tution were detected among five patients. These point mutations were the
same as previously reported in mitochondrial diseases or cardiomyopathies.
Thus, Point mutations of mtDNA may be related to the pathogenesis
of AHMD.
3:00
Point Mutations of Mitochondrial DNA in Alcoholic
Heart Muscle Disease
Masakazu Teragaki, Masahiko Takagi, Tomoko Tani, Minoru Yoshiyama. Iku Toda.
Kaname Akioka, Kazuhide Takeuchi, Tadanao Takeda. Masashi Tanaka 1,
Takayuki Ozawa 1. Osaka City University, Osaka, Japan; 1University of Nagoya,
Nagoya, Japan
Michihiro Suwa, Yoshiaki Ohtake, Ayaka Moriguchi, Yuzo Hirota,
Keishiro Kawamura, Itaru Adachi 1, Isamu Narabayashi 1. The 3rd Division, Dept of
Int. Med, Takatsuki, Osaka, Japan,' 1 Dept of Radial. Osaka Medical College, Takatsukl;
Osaka, Japan
Beta blocker (B) therapy is effective for some patients (pts) with DCM. Also, it
has been suggested that 1-123 Metaiodobenzylguanidine (MIBG) myocardial
imaging is useful to evaluate the severity of dilated cardiomyopathy (DCM).
However, there are no data which patients in DCM are effectual to B ther-
apy. This study was performed to evaluate whether MIBG can predict the
response to B therapy in pts with DCM. Therefore, MIBG imaging was per-
formed in 19 pts with DCM (M: 12, F: 7, age 13 to 68) before the start of
B (bisoprolol). The heart to mediastinum MIBG uptake ratio (HIM) was de-
